460470
🇰🇷XKOS.460470South KoreaHealthcare
Price₩2,600.00+15.00 (+0.58%)
Latest anomalies
Very positive 25 detected in the last 120 days
- High: 0
- Medium: 14
- Low: 10
Overnight gap: a gap up from the prior close
Volume: a spike above the 20-day average
Overnight gap: a gap up from the prior close
12-1M momentum: flipped sign, from negative to positive
12-1M momentum: flipped sign, from negative to positive
Free with a Finzer account.
Profile
- Healthcare
- Medical Devices
- South Korea
Identity
- Exchange
- KOSDAQ . XKOS
- Type
- Stock
- ISIN
- Not reported
- CUSIP
- Not reported
Company
- Employees
- 0
- Headquarters
- Daejeon, South Korea
- Website
- https://www.ivimtech.com
Market
- Shares outstanding
- 15.1M
- Market cap
- ₩39.25B
Highlights
- Market cap
- ₩39.25B
- EPS LTM
- Not reported
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- Not reported
- Net income
- Not reported
- Gross margin
- Not reported
- Free cash flow
- Not reported
Latest news
News is not sourced for this exchange.
Business summary
460470 is a company in the healthcare sector, listed on KOSDAQ (South Korea) under the ticker 460470. Its market capitalisation is ₩39.25B, from 15.1M shares outstanding, as of . Across the 240 trading sessions to the shares traded between ₩2,415.00 and ₩4,945.00, and the last close of ₩2,600.00 sits 7% of the way up that range. The company is headquartered in Daejeon, South Korea.
IVIM Technology, Inc. develops intravital microscopy (IVM) platform. Its products include IVM-C3, a system for simultaneously observing various multi-cellular behaviors in small live animal models; IVM-M3, a system for users who need to conduct deeper-tissue imaging using less-scattering NIR wavelength; IVM-CMS3 for intravital functional imaging; IVM-CM3 that provides three-dimensional imaging of living cells near the skin or deep into the tumor in small animals; IVM-MS3 for in vivo imaging; and IVM-customized products. The company also provides preclinical contract research organization services. Its products are used in live cell intravital imaging, repetitive intravital imaging, in vivo drug efficacy monitoring, in vivo drug delivery monitoring, and ex vivo imaging applications. The company was founded in 2017 and is based in Daejeon, South Korea.